What Is Fluoxetine? Brand Names: Prozac; Prozac Weekly; Sarafem

What is Fluoxetine?

What is Fluoxetine?

This post was written with Consensus AI Academic Search Engine - please read our Disclaimer at the end of this article. Fluoxetine is a widely used medication primarily known for its role as an antidepressant. It belongs to a class of drugs called selective serotonin reuptake inhibitors (SSRIs). This article explores the pharmacodynamics, therapeutic applications, and potential side effects of fluoxetine. Brand names include: Prozac; Prozac Weekly; Sarafem; Selfemra.

Pharmacodynamics and Pharmacokinetics

Fluoxetine functions by inhibiting the reuptake of serotonin, a neurotransmitter, thereby increasing its availability in the brain. This mechanism enhances serotoninergic neurotransmission, which is crucial for mood regulation4. The drug is metabolized in the liver to produce an active metabolite, norfluoxetine, both of which have long half-lives, facilitating steady-state plasma concentrations during long-term treatment4.

Therapeutic Applications of Fluoxetine

Depression

Fluoxetine is primarily indicated for the treatment of major depressive disorder (MDD). Clinical trials have demonstrated its efficacy in both adults and pediatric populations. For instance, a study showed that fluoxetine significantly improved depressive symptoms in children and adolescents with MDD compared to placebo3. Another meta-analysis confirmed that fluoxetine is effective in reducing suicidal ideation among depressed patients7.

Anxiety Disorders

Fluoxetine has also been found effective in treating various anxiety disorders in children and adolescents, including generalized anxiety disorder, separation anxiety disorder, and social phobia. Studies indicate that fluoxetine significantly reduces anxiety symptoms and improves overall functioning5.

Neurological Disorders

Emerging research suggests that fluoxetine may have therapeutic potential in treating neurological disorders. Preclinical studies have shown beneficial effects in animal models of stroke, multiple sclerosis, and epilepsy. Clinical studies have also reported improvements in neurological symptoms in conditions like Alzheimer's disease and traumatic brain injury, although these studies are often small and inconclusive2.

Weight Control

Fluoxetine has been investigated for its effects on weight control in overweight or obese adults. A systematic review found that fluoxetine might lead to modest weight loss compared to placebo, although the evidence is of low certainty. The drug appears to affect weight through appetite changes and normalization of eating behaviors1.

Posttraumatic Stress Disorder (PTSD)

Fluoxetine has shown efficacy in reducing symptoms of PTSD, particularly in non-veteran populations. It significantly reduces overall PTSD symptomatology, especially in the arousal and numbing symptom subcategories6. Learn more with Consensus: [button icon="๐Ÿ˜”" text="How does Fluoxetine function as a selective serotonin reuptake inhibitor (SSRI) in treating depression?"][/button] [button icon="๐Ÿง " text="Does Fluoxetine have potential benefits in treating neurological disorders such as stroke or multiple sclerosis?"][/button]

Side Effects and Safety of Fluoxetine

While fluoxetine is generally well-tolerated, it is not without side effects. Common adverse effects include nausea, nervousness, and insomnia4. In pediatric populations, fluoxetine is associated with mild and transient headaches and gastrointestinal side effects5. A meta-analysis found no significant increase in suicidal acts or ideation with fluoxetine compared to placebo or tricyclic antidepressants7. In specific conditions like stroke recovery, fluoxetine was found to reduce the occurrence of depression but increased the risk of bone fractures and hyponatremia, indicating a need for cautious use in such populations9. Learn more with Consensus: [button icon="๐ŸŒ€" text="What are the common adverse effects of Fluoxetine?"][/button]

How has Fluoxetine Improved Patient Outcomes?

Stroke Recovery Fluoxetine does not improve functional outcomes after acute stroke but reduces the occurrence of depression1 2 3 8 9 10. Increased risks of bone fractures, falls, and seizures were associated with fluoxetine use in stroke patients1 2 3 9. Depression in Advanced Cancer Patients Fluoxetine significantly improves overall quality of life and reduces depressive symptoms in advanced cancer patients4. Fibromyalgia Fluoxetine is effective in reducing pain, fatigue, and depressive symptoms in women with fibromyalgia, leading to improved overall outcomes6. Posttraumatic Stress Disorder (PTSD) Fluoxetine significantly improves quality of life, particularly in the domains of vitality, social functioning, and mental health for PTSD patients7. Learn more with Consensus: [button icon="๐Ÿ›Œ" text="How has Fluoxetine improved patient outcomes?"][/button]  

Fluoxetine Mechanisms of Action

Serotonin Reuptake Inhibition Fluoxetine primarily acts by inhibiting the serotonin reuptake transporter (SERT), thereby increasing serotonin levels in the synaptic cleft and enhancing serotonin signaling7 8. CYP450 Enzyme Interaction Fluoxetine and its active metabolite, norfluoxetine, inhibit the CYP2D6 enzyme, leading to prolonged inhibition even after discontinuation. This inhibition is likely due to competitive binding and the long elimination half-life of fluoxetine and norfluoxetine1. Neurotransmission Modulation Fluoxetine influences neurotransmission beyond serotonin. It affects acetylcholine (Ach), gamma-aminobutyric acid (GABA), and glutamate neurotransmission, and binds to serotonin receptors SER-7 and SER-5, which regulate AMPA receptor GLR-1 signaling7. Neurogenesis and Neuroprotection Fluoxetine promotes neurogenesis and increases the survival rate of neurons by upregulating proteins like Bcl-2, Bcl-xL, and c-FLIP. It also inhibits apoptosis in neural stem cells through the activation of the c-FLIP promoter region5. Glucose Metabolism in the Brain Fluoxetine enhances glucose uptake and glycolysis in astrocytes by modulating the GR-TXNIP-GLUT1 pathway, which is particularly relevant in corticosterone-induced depression2. Histone Deacetylase (HDAC) Inhibition Fluoxetine reduces neuroinflammation and depression-like behaviors by inhibiting HDAC1, which in turn affects eEF2 activity and synaptogenic factors like BDNF, SNAP25, and PSD953. Ion Channel Modulation Fluoxetine blocks voltage-gated potassium channels (Kv1.1), affecting neuronal repolarization processes. This blockade is both use- and dose-dependent and involves complex biophysical interactions10. Steroid Metabolism Fluoxetine elevates brain concentrations of the neuroactive steroid allopregnanolone by inhibiting a steroid microsomal dehydrogenase rather than activating an aldo-keto reductase6. Estrogenic Actions Fluoxetine may exert estrogen-like effects by activating the PI3K/AKT and ERK signaling pathways via GPR30, leading to cell proliferation in certain contexts, such as breast cancer cells9. Learn more with Consensus: [button icon="๐ŸŽฌ" text="What is Fluoxetine mechanism of action?"][/button]  

Common Complaints Associated with Fluoxetine Use

Neurological and Psychological Side Effects Anxiety and agitation are frequently reported side effects of fluoxetine1 2 4. Behavioral activation, including symptoms like restlessness and jitteriness, is common, particularly in children4 5. Gastrointestinal Complaints Nausea is a typical adverse effect experienced by patients on fluoxetine2. Sleep Disturbances Insomnia is a common complaint among fluoxetine users2 3. Fluoxetine does not significantly improve sleep continuity measures in patients with major depressive disorder and insomnia3. Fatigue and Somnolence Fatigue is another frequently reported side effect2. Somnolence before and after randomization was associated with a good placebo response in a study on geriatric depression1. Sexual Dysfunction Sexual dysfunction is a noted side effect of fluoxetine4. Extrapyramidal Symptoms Fluoxetine has been associated with various extrapyramidal side effects, including exacerbation of pre-existing conditions like restless legs syndrome4.  Learn more with Consensus: [button icon="๐Ÿ˜ด" text="Are sleep disturbances, such as insomnia, frequently reported by Fluoxetine users?"][/button] [button icon="๐Ÿง˜๐Ÿผโ€โ™€๏ธ" text="What gastrointestinal complaints are frequently reported by patients using Fluoxetine?"][/button]

Disclaimer

The content presented in this blog is generated by Consensus, an AI-powered academic search engine, and is based on publicly available scientific literature. While every effort is made to provide accurate, up-to-date, and well-researched information, the content is intended for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making any decisions regarding medical conditions, treatments, or medications. The AI system's analysis may not cover all perspectives, emerging research, or individual cases, and it is not a substitute for professional expertise. Neither the blog publisher nor the developers of the AI-powered search engine are responsible for any actions taken based on the information provided in this content. Use of this information is at your own risk. Citations to the original scientific studies are included for reference, but these studies should be reviewed in full and interpreted with the guidance of a healthcare or research professional. If you are experiencing a medical emergency, please seek immediate attention from a healthcare provider.

Start searching for free in Consensus!

Consensus searches through 220M+ peer reviewed research papers and provides you the best insights from them. Helping you find better papers, faster.

Sign Up